臨床外科67巻11号

2012年10月発行

特集 外科医のための癌診療データ

臓器別最新データ 6．肝癌

肝癌の疫学

著者： 田中英夫¹ 細野覚代¹ 伊藤秀美¹

所属機関： ¹愛知県がんセンター研究所疫学・予防部

ページ範囲：P.138 - P.142

文献概要

覚えておきたいデータ

◆わが国の肝癌罹患率は，C型肝炎ウイルスキャリアの減少により，減少傾向にある．

◆肝細胞癌患者に占める高齢者・女性の割合が増加している．

◆慢性ウイルス性肝炎患者を禁煙，禁酒させることで，肝細胞癌発症リスクを軽減するとともに，肝細胞癌罹患後の予後を改善することができる．

参考文献

1）Tanaka H, Tsukuma H：Characteristics of Japanese patients with liver cancer-epidemiological study based on a comparison between male and female patients. Hepatology Research 24：S11-S20, 2002

2）田中政宏，津熊英明：胆管細胞癌の疫学．日臨67：278-282（増刊3），2009

3）Matsuda T, Marugame T, Kamo K, et al：Cancer incidence and incidence rates in Japan in 2006：based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan（MCIJ）project. Jpn J Clin Oncol 42：139-147, 2012

4）Tanaka H, Imai Y, Hiramatsu N, et al：Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 148：820-826, 2008

5）Yang HI, Yeh SH, Chen PJ, et al：Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100：1134-1143, 2008

6）Yuen MF, Tanaka Y, Fong DY, et al：Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 50：80-88, 2009

7）Zhang H, Zhai Y, Hu Z, et al：Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42：755-758, 2010

8）IARC：Some naturally occurring substance：food items and constituents, heterocyclic aromatic and mycotoxins. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. Vol. 56. Lyon, 1993

9）Tsukuma H, Hiyama T, Tanaka S, et al：Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328：1797-1801, 1993

10）Shih WL, Chang HC, Liaw YF, et al：Influences of tobacco and alcohol use on hepatocellular carcinoma survival. Int J Cancer 2012 Feb 23. doi：10. 1002/ijc. 27508

11）Yang R, Gui X, Xiong Y, et al：Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese. Infection 39：427-431, 2011

12）Thomas DL：Hepatitis C and human immunodeficiency virus infection. Hepatology 36（5 Suppl 1）：S201-209, 2002

13）Tanaka K, Tsuji I, Tamakoshi A, et al：Obesity and liver cancer risk：an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 42：212-221, 2012

14）Larsson SC, Wolk A：Coffee consumption and risk of liver cancer：a meta-analysis. Gastroenterology 132：1740-1745, 2007

15）IARC：Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer, Vol. 61, Lyon, 1994, pp1-241

16）Tanaka M, Tanaka H, Tsukuma H, et al：Risk factors for intrahepatic cholangiocarcinoma：a possible role of hepatitis B virus. J Viral Hepat 17：742-748, 2010

17）Shin HR, Oh JK, Masuyer E, et al：Epidemiology of cholangiocarcinoma：an update focusing on risk factors. Cancer Sci 101：579-585, 2010